Log In
Print
BCIQ
Print
Print this Print this
 

Teysuno, tegafur/gimeracil/oteracil potassium (S-1, TS-1)

  Manage Alerts
Collapse Summary General Information
Company Taiho Pharmaceutical Co. Ltd.
DescriptionOral combination of 5-fluorouracil (5-FU) plus two enzyme inhibitors
Molecular Target Dihydropyrimidine dehydrogenase
Mechanism of ActionDihydropryimidine dehydrogenase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today